Literature DB >> 34695512

Adropin transgenesis improves recognition memory in diet-induced obese LDLR-deficient C57BL/6J mice.

Sarbani Ghoshal1, Subhashis Banerjee2, Jinsong Zhang2, Michael L Niehoff3, Susan A Farr4, Andrew A Butler5.   

Abstract

Obesity-related metabolic dysregulation causes mild cognitive impairment and increased risk for dementia. We used an LDLR-deficient C57BL/6J mouse model (LDLRKO) to investigate whether adropin, a neuropeptide linked to neurodegenerative diseases, improves cognitive function in situations of metabolic dysregulation. Adropin transgenic mice (AdrTG) were crossed with LDLRKO; male and female progeny were fed a high fat diet for 3-months. Male chow-fed wild type (WT) mice were used as controls. Diet-induced obesity and LDLR-deficiency caused severe dyslipidemia, irrespective of sex. The AdrTG prevented reduced adropin protein levels in LDLRKO cortex. In males, metabolic dysregulation and AdrTG genotype significantly and bi-directionally affected performance in the novel object recognition (NOR) test, a declarative hippocampal memory task (discrimination index mean ± SE for WT, 0.02 ± 0.088; LDLRKO, -0.115 ± 0.077; AdrTG;LDLRKO, 0.265 ± 0.078; genotype effect, p = 0.009; LDLRKO vs. AdrTG;LDLRKO, P < 0.05). A 2-way ANOVA (fixed variables: sex, AdrTG genotype) indicated a highly significant effect of AdrTG (P = 0.003). The impact of the diet-genotype interaction on the male mouse brain was investigated using RNA-seq. Gene-ontology analysis of transcripts showing fold-changes of>1.3 or <-1.3 (P < 0.05) indicated metabolic dysregulation affected gene networks involved in intercellular/neuronal signaling, immune processes, angiogenesis, and extracellular matrix organization. The AdrTG selectively attenuated the impact of metabolic dysregulation on intercellular/neuronal signaling pathways. Intercellular/neuronal signaling pathways were also the predominant processes overrepresented when directly comparing AdrTG;LDLRKO with LDRKO. In summary, adropin overexpression improves cognitive function in severe metabolic dysregulation through pathways related to cell-cell communication and neuronal processes, and independently of preventing inflammatory responses.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cognitive function; Dementia; Dyslipidemia; Learning; Obesity; Peptide therapy; Transgenic models

Mesh:

Substances:

Year:  2021        PMID: 34695512      PMCID: PMC8649943          DOI: 10.1016/j.peptides.2021.170678

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  39 in total

Review 1.  Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics.

Authors:  Sheila Collins; Tonya L Martin; Richard S Surwit; Jacques Robidoux
Journal:  Physiol Behav       Date:  2004-04

2.  Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans.

Authors:  Andrew A Butler; Charmaine S Tam; Kimber L Stanhope; Bruce M Wolfe; Mohamed R Ali; Majella O'Keeffe; Marie-Pierre St-Onge; Eric Ravussin; Peter J Havel
Journal:  J Clin Endocrinol Metab       Date:  2012-08-07       Impact factor: 5.958

Review 3.  Neurological consequences of obesity.

Authors:  Phillipe D O'Brien; Lucy M Hinder; Brian C Callaghan; Eva L Feldman
Journal:  Lancet Neurol       Date:  2017-06       Impact factor: 44.182

4.  D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet.

Authors:  Georgette M Buga; Joy S Frank; Giuliano A Mottino; Michael Hendizadeh; Ashkan Hakhamian; Jan H Tillisch; Srinivasa T Reddy; Mohamad Navab; G M Anantharamaiah; Louis J Ignarro; Alan M Fogelman
Journal:  J Lipid Res       Date:  2006-07-11       Impact factor: 5.922

Review 5.  Molecular dissection of reactive astrogliosis and glial scar formation.

Authors:  Michael V Sofroniew
Journal:  Trends Neurosci       Date:  2009-09-24       Impact factor: 13.837

6.  Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies.

Authors:  Kapil Gudala; Dipika Bansal; Fabrizio Schifano; Anil Bhansali
Journal:  J Diabetes Investig       Date:  2013-04-26       Impact factor: 4.232

7.  Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance.

Authors:  Su Gao; Ryan P McMillan; Qingzhang Zhu; Gary D Lopaschuk; Matthew W Hulver; Andrew A Butler
Journal:  Mol Metab       Date:  2015-01-17       Impact factor: 7.422

8.  Reduced cognitive function, increased blood-brain-barrier transport and inflammatory responses, and altered brain metabolites in LDLr -/-and C57BL/6 mice fed a western diet.

Authors:  Jennifer M Rutkowsky; Linda L Lee; Michelle Puchowicz; Mari S Golub; Douglas E Befroy; Dennis W Wilson; Steven Anderson; Gary Cline; Jason Bini; Kamil Borkowski; Trina A Knotts; John C Rutledge
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

9.  Obesity and dietary fat influence dopamine neurotransmission: exploring the convergence of metabolic state, physiological stress, and inflammation on dopaminergic control of food intake.

Authors:  Conner W Wallace; Steve C Fordahl
Journal:  Nutr Res Rev       Date:  2021-06-28       Impact factor: 8.146

10.  An accelerated mouse model for atherosclerosis and adipose tissue inflammation.

Authors:  Angelika Neuhofer; Bernhard Wernly; Lukas Leitner; Alisina Sarabi; Nicole G Sommer; Günther Staffler; Maximilian Zeyda; Thomas M Stulnig
Journal:  Cardiovasc Diabetol       Date:  2014-01-17       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.